Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/love-can-help-initiated
https://www.med.cuhk.edu.hk/press-releases/love-can-help-initiated

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

香港中文大學(中大)醫學院於昨晚透過社交媒體作出緊急呼籲,為本院醫科畢業生張俊傑醫生患有罕見心臟病及第四期神經母腫瘤的17個月大兒子張可仁籌集治療費用。李嘉誠基金會今天(11月23日)宣佈即時額外注入200萬元予《愛能助》醫療計劃,讓中大能及時幫助有關患有罕見癌症的兒童。

 

張俊傑醫生為中大醫學院2000年醫科畢業生。其兒子張可仁早於出生第4天時已被診斷罹患一種罕有心臟病「主動脈狹窄」,需要接受緊急手術。可仁最近再被確診患上「第四期神經母腫瘤」,目前他的頭骨至腰椎和盆骨均受到癌細胞擴散,癌細胞壓着脊髓神經線,有癱瘓的危機,癌細胞更正轉移至骨髓。

 

可仁的治療方案包括化療、手術、放射治療、骨髓移植、免疫治療,為期一年至一年半。免疫療法可將存活率提升至50%。但免疫治療需要病人自費,所需費用高達港幣200萬元。然而,張醫生另一兒子患有自閉症,太太辭掉小學主任一職,全職照顧兩位小朋友,並要照顧父母親,經濟上未能承擔高昂的醫療費用。

 

李嘉誠基金會早前公布透過《愛能助》醫療計劃支持本港兩所醫學院的研究工作,並對其轄下教學醫院的指定範圍病人,提供醫療資助,減低他們財政上的負擔。中大醫學院建議的重點項目包括為癌症病人提供新型治療癌症藥物或裝置,以改善患者病情或減少複雜併發症。

 

鑑於可仁的病情及治療方案複雜,需要「免疫療法」此較新型的癌症治療方法,正正是《愛能助》計劃關注的病人,因此基金會特意提早啟動相關的資助項目,讓可仁及患有相類罕見兒童癌症的患者可盡快得到有關治療及幫助。

 

李嘉誠基金會主席李嘉誠先生得悉張醫生一家的情況後,深表關注,昨晚聯絡霍泰輝教授,希望可立即啟動《愛能助》下相關的兒童罕見癌症資助項目,讓張家得到所需資助,以解燃眉之急,並請霍教授向張醫生和家人轉達安慰和鼓勵。李先生亦十分希望事件能引發社會各界對兒童罕見癌症治療的關注。

 

張俊傑醫生表示﹕「同時罹患『主動脈狹窄』及『第四期神經母腫瘤』是1億份之1的機會,可仁遇上了。雖然我們也不明白事情為什麼會發生,但都會積極面對及接受治療。我們很感激李嘉誠先生及李嘉誠基金會的慷慨,也多謝社會各界的關心,這些支持對可仁和我們一家都十分寶貴。」

 

關於《愛能助》醫療計劃

目前社會上雖然已有安全網為綜援人士和合資格申請關愛基金或撒瑪利亞基金的人士提供資助,減輕他們的醫療開支,但仍有不少平時有自顧能力的家庭在面對某些疾病時,醫療開支頓成重擔,一籌莫展,對此醫護人員很多時也感到無奈及愛莫能助。

 

有見及此,李嘉誠基金會本年8月19日宣佈捐資1億元,在醫管局和香港大學、中文大學支持下推出《愛能助》醫療計劃,其中向兩所大學醫學院各捐資1,750萬元,為未能得到政府資助的「夾心基層」病患者提供經濟支援。

More Press Releases

CUHK unlocks the secret of cancer pain  Identifying a new therapeutic key to ending the sorrow

CUHK unlocks the secret of cancer pain Identifying a new therapeutic key to ending the sorrow

Research
CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

Research
CUHK’s study sees a rising trend of multiple myeloma incidence,  particularly in older males from high-income countries

CUHK’s study sees a rising trend of multiple myeloma incidence, particularly in older males from high-income countries

Research
CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

Donation
CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

Research
CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

Research
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
CUHK Receives HK$30 million Donation from Li Ka Shing Foundation to Enhance Research Space and Facilities at CU Medicine

CUHK Receives HK$30 million Donation from Li Ka Shing Foundation to Enhance Research Space and Facilities at CU Medicine

Donation
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK Receives Nearly HKD 78 Million from HKJC to Launch Ophthalmic Programmes for Children’s Eye Care and Ophthalmic Microsurgical Training

CUHK Receives Nearly HKD 78 Million from HKJC to Launch Ophthalmic Programmes for Children’s Eye Care and Ophthalmic Microsurgical Training

Donation
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
10th Palliative Care Symposium for Healthcare Workers in Chinese Population: ‘Succession ‧ Innovation’

10th Palliative Care Symposium for Healthcare Workers in Chinese Population: ‘Succession ‧ Innovation’

Symposium
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
The 9th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Integrating Palliative Care into General Care: Paving the Way for the Future’

The 9th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Integrating Palliative Care into General Care: Paving the Way for the Future’

Symposium
CUHK Launches ‘Lui Che Woo Distinguished Young Scholars Award’ Over HKD 15 Million Worth of Scholarship to Support Medical Students’ Pursuit of Postgraduate Research Overseas

CUHK Launches ‘Lui Che Woo Distinguished Young Scholars Award’ Over HKD 15 Million Worth of Scholarship to Support Medical Students’ Pursuit of Postgraduate Research Overseas

Donation
CUHK Pao So Kok Macular Disease Treatment and Research Centre Opens Study Sees Correlation between Protein Angiopoietin2 and Wet Age-related Macular Degeneration

CUHK Pao So Kok Macular Disease Treatment and Research Centre Opens Study Sees Correlation between Protein Angiopoietin2 and Wet Age-related Macular Degeneration

Donation
The 8th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Advancing Palliative Care in Hong Kong: Opportunities and Challenges’

The 8th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Advancing Palliative Care in Hong Kong: Opportunities and Challenges’

Symposium
CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

Donation
CUHK Establishes Chow Yuk Ho Technology Centre for Innovative Medicine An Interdisciplinary Collaboration to Transfer Biomedical Engineering Research into Clinical Practice

CUHK Establishes Chow Yuk Ho Technology Centre for Innovative Medicine An Interdisciplinary Collaboration to Transfer Biomedical Engineering Research into Clinical Practice

Donation
The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

Symposium
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
The 6th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care for Geriatric Cancer Patients’

The 6th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care for Geriatric Cancer Patients’

Symposium
CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

Donation
CUHK Held Naming Ceremony of the Lui Che Woo Clinical Sciences Building Today

CUHK Held Naming Ceremony of the Lui Che Woo Clinical Sciences Building Today

Milestone
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

Symposium
The Lee Wing Kit Advanced Ophthalmic Training and Education Centre Opens Today

The Lee Wing Kit Advanced Ophthalmic Training and Education Centre Opens Today

Donation
CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

Surgical advancement
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

Milestone
CUHK's Youth Urological Treatment Centre Opens Today Territory's First Centre to Provide Urological Assessment and Treatment to Young Drug Abusers

CUHK's Youth Urological Treatment Centre Opens Today Territory's First Centre to Provide Urological Assessment and Treatment to Young Drug Abusers

Donation
The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

Symposium
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.